References
- Griffin B, Farish E, Walsh D, et al. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause. Clin Endocrinol 1993; 39: 463–8
- Castelo-Branco C, Casals E, Sanllehy C, et al. Effect of oophorectomy and hormone replacement therapy on plasma lipids. Maturitas 1993; 17: 113–22
- Kritz-Silverstein D, Barrett-Connor E, Wingard D L. Hysterectomy, oophorectomy and heart disease risk factors in older women. Am J Public Health 1997; 87: 676–80
- Montgomery J C, Crook D, Godsland IFI, et al. Plasma lipid risk factors in oophorectomize woman. Br J Obstet Gynaecol 1989; 96: 1236–8
- Farish E, Fletcher C D, Hart D M, et al. Effect of bilateral oophorectomy on lipoprotein metabolism. Br J Obstet Gynaecol 1990; 97: 78–82
- Bruschi F, Meschia M, Soma M, et al. Lipoprotein (a) and other lipids after oophorectomy and estrogen replacement therapy. Obstet Gynecol 1996; 88: 950–4
- Orth-Gomer K, Mitdeman M A, Schenck-Gustafsson K, et al. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation 1997; 95: 329–34
- Pansini F, Bergamini C, Bettochi S, et al. Short term effect of oophorectomy on lipoprotein metabolism. Gynecol Obstet Invest 1984; 18: 134–9
- Sonnendecker EWW, Polakow E S, Benade AJS, et al. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen–medrogestone regimen in hysterectomized postmenopausal women. Am J Obstet Gynecol 1989; 160: 1128–34
- Castelli W P. Epidemiology of coronary heart disease: The Framingham study. Am J Med 1984; 76: 4–12
- Punnonen R, Rauramo L. The effect of castration and estrogen therapy on serum high-density lipoprotein cholesterol. Int J Gynaecol Obstet 1980; 17: 434–6
- Notelovitz M, Johnston M, Smith S, et al. Metabolic and hormonal effect of 25-mg and 50-mg 17β-estradiol implants in surgically menopausal women. Obstet Gynecol 1987; 70: 749–54
- Hennekens C H. Hormone replacement therapy: current perspectives and future directions. Eur Heart J 1997; 18: 1362–3
- Wild R A, Taylor E L, Knehans A. The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol 1995; 172: 1–13
- Brush T L, Miller V T. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. Menopause: Physiology and Pharmacology, DR Mishell. Year Book Medical, Chicago 1987; 187–208
- Erenus M, Kutlay K, Kutlay L. Comparasion of the impact of oral versus transdermal estrogen on serum lipids. Fertil Steril 1994; 61: 300–2
- Walsh B W, Schiff I, Rosner B. Effect of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 196–204
- Weinstein L. Hormonal therapy in the patient with surgical menopause. Obstet Gynecol 1990; 75: 47s–50s
- Lindsay R. The menopause: sex steroids and osteoporosis. Clin Obstet Gynecol 1987; 30: 847–9
- Thorneycroft I H. The role of estrogen replacement therapy in the prevention of osteoporosis. Am J Obstet Gynecol 1989; 160: 1306–10